Sirak Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.34 Cr
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.48 Cr
- Satisfied Charges ₹ 4.95 Cr
- Revenue Growth 80.33%
- Profit Growth 189.85%
- Ebitda 201.04%
- Net Worth 99.67%
- Total Assets 28.85%
About Sirak Pharmaceuticals
Sirak Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 January 2008 and has a history of 17 years and four months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.34 Cr.
The company currently has active open charges totaling ₹11.48 Cr. The company has closed loans amounting to ₹4.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Satya Vakkalanka, Swaroopkumar Vakkalanka, and Thappali Manikandan serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TG2008PTC057045
- Company No.
057045
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jan 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Sirak Pharmaceuticals Private Limited
Explore comprehensive data for Sirak Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Sirak Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swaroopkumar Vakkalanka  | Director | 08-Jan-2008 | Current |
| Satya Vakkalanka | Director | 08-Jan-2008 | Current |
| Thappali Manikandan | Director | 31-Mar-2022 | Current |
Financial Performance of Sirak Pharmaceuticals.
Sirak Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 80.33% increase. The company also saw a substantial improvement in profitability, with a 189.85% increase in profit. The company's net worth Soared by an impressive increase of 99.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sirak Pharmaceuticals?
Unlock access to Sirak Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Incozen Therapeutics Private LimitedSatya Vakkalanka and Thappali Manikandan are mutual person
- Sirak Research Labs Llp
Satya Vakkalanka is a mutual person
Charges (Loans)
Open Charges
₹11.48 Cr
Satisfied Charges
₹4.95 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 7.45 Cr
- Hdfc Bank Limited : 4.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Feb 2024 | Hdfc Bank Limited | ₹4.03 Cr | Open |
| 29 Oct 2022 | Yes Bank Limited | ₹7.45 Cr | Open |
| 29 Feb 2020 | Yes Bank Limited | ₹1.00 Cr | Satisfied |
| 01 Nov 2016 | Hdfc Bank Limited | ₹2.45 Cr | Satisfied |
| 17 Apr 2015 | Hdfc Bank Limited | ₹1.50 Cr | Satisfied |
How Many Employees Work at Sirak Pharmaceuticals?
Unlock and access historical data on people associated with Sirak Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sirak Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sirak Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Sirak Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Sirak Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Sirak Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.03 Cr with Charge ID 100865612 was registered on 06 Feb 2024.
- Charges
A charge with Yes Bank Limited amounted to Rs. 7.45 Cr with Charge ID 100628562 was registered on 29 Oct 2022.
- Charges
A charge registered on 01 Nov 2016 via Charge ID 100098221 with Hdfc Bank Limited was fully satisfied on 23 May 2022.
- Charges
A charge registered on 17 Apr 2015 via Charge ID 10575969 with Hdfc Bank Limited was fully satisfied on 10 May 2022.
Frequently asked questions
What is the Incorporation or founding date of Sirak Pharmaceuticals Private Limited?
Sirak Pharmaceuticals Private Limited was incorporated on 08 Jan 2008.
What is authorized share capital and paid-up capital of Sirak Pharmaceuticals Private Limited?
The authorized share capital of Sirak Pharmaceuticals Private Limited is ₹ 1.50 Cr and paid-up capital is ₹ 1.34 Cr.
Who are the current board members & directors of Sirak Pharmaceuticals Private Limited?
Currently 3 directors are associated with Sirak Pharmaceuticals Private Limited.
- Satya Kameswari Vakkalanka
- Swaroopkumar Venkata Satya Vakkalanka
- Thappali Ramaswamy Sethuraman Satheesh Manikandan
What is the registered address of Sirak Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Sirak Pharmaceuticals Private Limited is Office No. 01B1 12A01B1 12A (13Th) Floor Manjeera Trinity Corporation Jntu Rd, K Ukatpally India, Hyderabad, Telangana, 500072.
What is the corporate identification number (CIN) and company number of Sirak Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Sirak Pharmaceuticals Private Limited is U24232TG2008PTC057045 and the company number is 057045 as per Ministry of Corporate Affairs (MCA).
What is the official website of Sirak Pharmaceuticals Private Limited?
The Official website of Sirak Pharmaceuticals Private Limited is https://www.sirakpharma.com
What has been the recent revenue trend for Sirak Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Sirak Pharmaceuticals Private Limited has risen by 80.33%.
What change has been observed in the net worth of Sirak Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Sirak Pharmaceuticals Private Limited has experienced an upsurge of 99.67%.
What are the total open charges for Sirak Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Sirak Pharmaceuticals Private Limited amount to ₹ 11.48 Cr.
When was the last Balance Sheet of Sirak Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Sirak Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records